跳至主要内容
临床试验/JPRN-UMIN000005025
JPRN-UMIN000005025尚未招募未知

Examination of treatment utility and advantage of taking medicine in which acknowledgment function improvement in patient with schizophrenia with new antipsychotic is made main axis - Examination of treatment utility and advantage of taking medicine in which acknowledgment function improvement in patient with schizophrenia with new antipsychotic is made main axis

Department of Psychiatry,Kobe University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • In case of patients with diabetic mellitus is excluded because Olanzapine is contraindicated drug.

研究者

发起方
Department of Psychiatry,Kobe University Graduate School of Medicine

相似试验